CD47 and cancer: Thus, further investigations are needed to reveal the underlying mechanisms of CD47 blockade for cancer treatment, such as the impacts of the oncolytic adenovirus SG635‐SF on the differentiation and stress response of target cells, its effect on cancer stem cells, and how to incorporate other important factors related to the targeting effects in the SG635‐SF design.